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Abstract
Construction of synthetic genetic networks requires the assembly of DNA fragments encoding functional
biological parts in a defined order. Yet this may become a time-consuming procedure. To address this
technical bottleneck, we have created a series of Gateway shuttle vectors and an integration vector,
which facilitate the assembly of artificial genes and their expression in the budding yeast Saccharomyces
cerevisiae. Our method enables the rapid construction of an artificial gene from a promoter and an open
reading frame (ORF) cassette by one-step recombination reaction in vitro. Furthermore, the plasmid thus
created can readily be introduced into yeast cells to test the assembled gene’s functionality. As flexible
regulatory components of a synthetic genetic network, we also created new versions of the tetracycline-
regulated transactivators tTA and rtTA by fusing them to the auxin-inducible degron (AID). Using our
gene assembly approach, we made yeast expression vectors of these engineered transactivators, AIDtTA
and AIDrtTA and then tested their functions in yeast. We showed that these factors can be regulated by
doxycycline and degraded rapidly after addition of auxin to the medium. Taken together, the method for
combinatorial gene assembly described here is versatile and would be a valuable tool for yeast synthetic
biology.
Introduction
Recent progress in synthetic biology has made it possible to engineer gene regulatory networks with
predictable behaviors [1]. Construction of de novo gene networks requires efficient assembly of DNA
sequences including promoters and ORFs encoding proteins with defined functions. Yet such DNA
assemblies are often time-consuming, typically involving ad hoc procedures such as restriction digestions
and DNA ligations. An alternative method for gene assembly is the multisite Gateway recombination
cloning [2]. This system enables rapid and highly efficient construction of an expression vector containing
multiple DNA fragments in vitro from the so-called Entry clones and a Destination vector. A recent study
applied this cloning technology successfully to the yeast one-hybrid system [3]. In this system a library
of DNA bait sequences and ORFs encoding the reporters (His3 and β-galactosidase) were assembled in
a one-step Gateway recombination reaction. The cloned plasmids were then integrated at the HIS3 and
URA3 loci for screening [3–5]. However, the Gateway vectors for the one-hybrid system were not designed
as versatile plasmid vectors for more general use to build artificial genes and introduce them into yeast.
Such vectors should facilitate the rapid characterization of new promoter-ORF combinations prior to the
synthesis of an artificial genetic network in yeast.
In an effort to aid gene network construction in budding yeast Saccharomyces cerevisiae, we have
adopted an approach similar to the one-hybrid system and created Gateway Destination vectors. These
new Destination vectors are based upon the pRS series of yeast centromere plasmids [6] and an integration
vector [7]. In addition, we have constructed a set of Entry clones harboring promoters and ORFs. An
artificial gene from a promoter and an ORF Entry clones can be assembled in a Destination vector by
one-step recombination reaction in vitro.
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2To increase the flexibility of regulation of synthetic genetic networks in yeast, we engineered two
transcriptional transactivators, AIDtTA and AIDrtTA. Each of these are a fusion of well-characterized
functional protein domains, the auxin-inducible degron (AID) [8] and the tetracycline-regulated trans-
activator (tTA and rtTA) [9]. tTA activity is downregulated in the presence of tetracycline antibiotics
such as doxycycline, while rtTA is activated by the antibiotic. In the AID system, a plant hormone auxin
binds to Tir1, an F-box protein, which in turn induces rapid degradation of the target protein fused to
AID [8]. Using our Gateway vectors and the recombination cloning method, we constructed expression
vectors of AIDtTA and AIDrtTA and tested their functions in yeast. We also constructed a destabi-
lized version of Venus (enhanced YFP) ORF, yEVenus-Cln2PEST-NLS, to be expressed as a fluorescent
reporter protein. Taken together, these resources provide a technological platform to assemble and test
a new promoter-ORF combination efficiently in yeast.
Results
Construction of yeast Gateway vectors for one-step gene assembly
To construct Gateway Destination vectors for assembling a promoter and an ORF, we cloned the DNA
sequences for site-specific recombination and terminators for gene expression into the pRS series of yeast
centromere plasmids [6] and an integration vector [7]. Table 1 is the list of Destination vectors created
in this study (see Materials and Methods for details). We also made a collection of promoter and ORF
Entry clones by Gateway BP recombination reactions (Table 2). The constructed Destination vectors
(Fig. 1) can be recombined with a promoter Entry clone and an open reading frame (ORF) Entry clone
in a one-step Gateway LR reaction in vitro (Fig. 2). These promoters and ORFs were cloned in the
Gateway Donor vectors in a specific direction so that assembled genes in expression vectors are always in
the same orientation relative to the recombination sites, in the order of attB2-[promoter]-attB5-[ORF]-
attB1-[TEF or CYC1 terminator]. The attB5 sequence (5’-CAACTTTTGTATACAAAGTTG-3’) has no
noticeable side effect on the gene expression from vectors so far created by this method. A recent study
has also applied the Gateway system successfully for a yeast one-hybrid system, in which a single attB1
recombination sequence is created between a promoter and an ORF as a by-product of the recombination
event [3–5]. The attB5 ’scar’ left behind by LR reactions may therefore be unlikely to interfere with the
assembled gene’s expression.
One of the Destination vector we have created (pDEST375) allows integration of the artificial gene
made by a Gateway recombination reaction at the MET15 locus (Fig. 3). This construct is based on the
integration vector pIS375, which allows a single-copy integration of the gene at the MET15 locus [7]. The
integrated constructs are highly stable because a duplicated copy of MET15 and the flanking plasmid
sequences including the URA3 marker gene are removed by homologous recombination [7] (Fig. 3). It
enables a recycling of URA3 marker gene for subsequent gene integrations at other loci in the genome.
pDEST375 was used for the integration of TEF-AIDrtTA gene (see below and Materials and Methods
for details). For the detailed description of this class of integration/disintegration vectors, see Sadowski
et al. [7].
We have performed a number of Gateway LR reactions using these plasmids with various combinations
of promoters and ORFs to create Yeast/E. coli shuttle vectors. The vectors thus created for this study are
listed in Table 3. An example of the expression vector CUP1 -yEVenus-Cln2PEST-NLS construct (pCM25)
is shown in Fig. 4A. The CUP1 promoter can be induced by copper [10,11]. yEVenus-Cln2PEST-NLS is a
fusion of the enhanced yellow fluorescent protein Venus (yEVenus), the Cln2PEST (which destabilizes the
protein fused to it [10]) and the SV40 nuclear localization signal (NLS). The expression of the fluorescence
reporter yEVenus-Cln2PEST-NLS was observed after one hour following the addition of the inducer copper
nitrate (Fig. 4A, middle panels). Similar level of fluorescence was also detected at six hours (Fig. 4A,
bottom panels). When the culture media was replaced with the one without copper after induction for
3two hours, the fluorescence disappeared by six hours after the initial induction (data not shown). We
compared the fluorescence produced by yEVenus-Cln2PEST-NLS and yEVenus-NLS when expressed by
the constitutive promoter ADH1 (Fig. 4B, C). The fluorescence by ADH1-yEVenus-Cln2PEST-NLS (Fig.
4B) was much weaker than that by ADH1-yEVenus-NLS (Fig. 4C), indicating that Cln2PEST indeed
destabilizes yEVenus.
All but a few expression vectors have no non-specific effect on the cell growth: we have found that the
yeast cells with TEF-tTA (pCG112), and TEF-AIDtTA (pCG106; described below) grow poorly with an
unknown reason (data not shown). It has been reported that an autoregulatory construct of tTA with
a TetO7 promoter causes cell growth retardation when introduced in the hamster glioblastoma cell line
HJC-15 [12]. The mechanism of this delay of cell proliferation remains unclear.
Construction and characterization of tunable transactivators AIDtTA and
AIDrtTA
To fuse an AID to the N-terminus of tTA and rtTA, we have used a method that combines a Gateway BP
reaction in vitro and a homologous recombination in vivo in E. coli [13] (See Materials and Methods for
details). To verify the auxin-dependent degradation of AIDtTA and AIDrtTA, the yeast strain (YS114)
with an integrated copy of O. sativa TIR1 gene (ADH1-OsTIR1 ) was transformed with a vector harboring
ADH1-AIDtTA gene (pDHM19). The transformed cells were grown in liquid medium and treated with
1-naphthaleneacetic acid (NAA, a synthetic analog of auxin) or left untreated. Cells were then harvested
0.5, 3 and 4 hours after the addition of NAA, and the expression of AIDtTA was examined by Western
blotting using a monoclonal anti-TetR antibody (Fig. 5A and B; note that different anti-TetR and anti-
Myc antibodies were used in panel A and B ). As shown in Fig. 5A, AIDtTA was efficiently degraded by
3 hours following the addition of NAA. This degradation depended on the expression of OsTIR1 (tagged
with 9xMyc epitope). The AID was also required for the degradation as the expression of untagged tTA
was not affected in YS114 strain in the presence of NAA (Fig. 5B). Likewise, AIDrtTA was degraded
in NAA-dependent manner in YS114 strain (with OsTIR1), but not in YS129 (without OsTIR1) (Fig.
5C). When AIDrtTA was expressed by the strong TEF promoter in YS114 strain, a fraction of AIDrtTA
protein remained intact even 4 hours after the addition of NAA to the medium (Fig. 5D).
Next, we verified the activity of AIDtTA as a transcriptional activator. YS129 yeast strain was
transformed with the reporter plasmid construct pCG87 (TetO7-mCherry-NLS ; mCherry fluorescent
protein reporter construct) together with pCG84 (ADH1-tTA) or pDHM19 (ADH1-AIDtTA). As shown
in Fig. 6, tTA and AIDtTA are active in the absence of doxycycline (-DOX). Because tTA or AIDtTA
activity is supposed to be suppressed in the presence of DOX, mCherry reporter fluorescence should be
reduced after treating cells with DOX. After 7 hours following the addition of DOX to the medium,
however, significant fluorescence still remained (Fig. 6B and C, +DOX). This is presumably because the
half-life of mCherry is relatively long and it may take longer to see the reduction of the fluorescence after
addition of DOX, which is consistent with the results of flow cytometry (see below).
We asked whether any rapid reduction of fluorescence after the suppression of AIDtTA activity by
DOX and NAA can be achieved using yEVenus-Cln2PEST as a reporter. For this, we used a diploid
strain (JW003) with a copy of ADH1-OsTIR1 and a reporter TetO7-yEVenus-Cln2PEST genes integrated
in the genome. JW003 was transformed with pDHM19 (ADH1-AIDtTA). Note that both AIDtTA and
OsTIR1 was expressed by constitutively active ADH1 promoter. The yeast cells were then cultured in
the presence or absence of NAA or DOX alone, or both together. Fig. 7A shows a schematic diagram
of the gene regulation by AIDtTA in this strain. Without the inducers DOX or NAA, Venus (YFP)
fluorescence was clearly visible in the nucleus (Fig. 7B). Cells without the plasmid (pDHM19; ADH1-
AIDtTA) showed no fluorescence (data not shown). After 1 hour of treatment with DOX, NAA or both,
no obvious decrease of fluorescence was observed (Fig. 7C, upper left panels). The addition of DOX took
effect in 2 hours, with much reduced fluorescence in the presence of the inducer either alone or together
4with NAA (Fig. 7C, upper right panels). It took 3 hours for NAA alone to suppress effectively the
expression of the reporter yEVenus-Cln2PEST (Fig. 7C, lower left panels). By 4 hours after the addition
of the inducers, fluorescence was greatly reduced in all cases (Fig. 7C, lower right panels). The cells
treated with both DOX and NAA showed more pronounced reduction of fluorescence than those with
either DOX or NAA alone. These results indicate that AIDtTA activity can be controlled efficiently by
DOX and NAA. DOX took effect faster than NAA perhaps partly because DOX directly inhibits the
reporter gene induction by AIDtTA while NAA acts indirectly by promoting the degradation of AIDtTA.
We tested two concentrations of NAA at 0.5mM and 2mM: increasing the concentration of NAA did
not accelerate the reduction of the fluorescence (the results with 2mM NAA is shown in Fig. 7). We
also performed a similar experiment using YS114 strain (with an integrated ADH1-OsTIR1 ) transformed
with two plasmids pDHM19 (ADH1-AIDtTA) and pCG103 (TetO7-yEVenus-Cln2PEST): similar profile
of reduction in fluorescence was observed after cells were treated with DOX and NAA, although the level
of fluorescence was more heterogeneous across the cell population in all conditions tested than that in
JW003 strain (data not shown).
The same set of yeast strains used in Fig. 6, i.e., YS129 or YS114 with two vectors pCG87 (mCherry
reporter plasmid) and pCG84 (ADH1-tTA) or pDHM19 (ADH1-AIDtTA) were subjected to flow cytom-
etry to examine the gene expression control by AIDtTA (Fig. 8A-C). Cells were treated with either
doxycycline (+DOX; broken green lines) or NAA alone (+NAA; cyan), or both (+DOX & NAA; orange)
for 7 hours, or left untreated (no inducers; broken magenta). Consistent with the observation by fluo-
rescence microscopy (Fig. 6), tTA and AIDtTA were equally active in the absence of doxycycline and
NAA (broken magenta lines in Fig. 8A-C), and induced the expression of the mCherry reporter fluo-
rescent protein. After addition of DOX (broken green lines), the fluorescence of the reporter decreased
as expected for both strains expressing tTA and AIDtTA. A large fraction of cells, however, have the
fluorescence well above the basal level of the reporter plasmid (< 102 arbitrary fluorescence units, data
not shown). In the presence of NAA (cyan lines), the mCherry expression decreased only in the cells
with both AIDtTA and OsTIR1 expressed (Fig. 8C). These results are consistent with the NAA- and
OsTIR1-dependent degradation of AIDtTA detected by Western blots (Fig. 5A and B).
We also tested the doxycycline-dependent gene expression by AIDrtTA and its degradation in OsTIR1-
and NAA-dependent manner (Fig. 9). The YS114 (with OsTIR1) and YS129 (without OsTIR1) strains
transformed with the plasmids pCG87 (mCherry reporter construct) and pCG107 (TEF-AIDrtTA) (Fig.
9A) were cultured in the presence or absence of DOX or NAA for 5 hours, and observed by fluorescence
microscopy (Fig. 9B). Expression of the fluorescent reporter mCherry was detected in response to +DOX
in both YS114 and YS129 strains (Fig. 9B, middle panels). In contrast, when DOX was added to the cell
together with NAA (+DOX&NAA), the reporter expression was inhibited in YS114 strain (Fig. 9B, right
bottom panels). The expression of mCherry was not affected in the absence of OsTIR1 after addition of
NAA (Fig. 9B, left bottom panels). DOX-dependent expression of reporter fluorescent proteins was also
observed using the strain with an integrated copy of TEF-AIDrtTA (MM017; Fig. 9C).
Those yeast strains used for fluorescence microscopy were also examined by flow cytometry (Fig.
8D-F). The results confirmed the DOX-dependent activation (green broken line) by AIDrtTA (Fig 8E
and F). The data also demonstrated the NAA-dependent reduction (orange line) of fluorescent reporter
proteins in cells expressing AIDrtTA and OsTIR1 (Fig 8F). In Fig 8D-F, the data for cells treated with
NAA alone are not shown, which have similar distribution of fluorescence as those of untreated ones
(No inducers; broken magenta lines). YS129 (the strain without OsTIR1) with TEF-AIDrtTA showed
around five fold decrease in fluorescence when DOX was added together with NAA (Fig 8E, green broken
and orange lines); the reason for this reduction in fluorescence remains unknown. We also found that
when rtTA expression was induced by the strong promoter TEF, it activated the reporter gene in the
absence of DOX (Fig 8D, magenta broken line). Such spurious DOX-independent activation of the TetO
promoter by rtTA was not observed when its expression was induced by moderate ADH1 promoter (data
not shown).
5Discussion
In this study, we have created a set of versatile Gateway Destination vectors and a collection of promoter
and ORF Entry clones to facilitate gene network construction. The multisite Gateway technology enables
the efficient assembly of a promoter and an ORF in a one-step recombination reaction in vitro. An
expression vector generated by this method can readily be introduced into yeast for functional assays of
the assembled gene. A similar combinatorial approach was demonstrated to be an efficient method for
producing diverse phenotypes of synthetic networks in E. coli [14]. The Destination vector pDEST375
described above allows a stable single-copy integration of an artificial gene at MET15 locus, adding a
flexible option for engineering artificial gene networks in yeast. We plan to construct similar Gateway
vectors for integration at the other chromosome locus utilized by Sadowski et al. [7], such as ADE8, FCY1
and LYS2.
The collection of Entry clones for our gene assembly strategy may be expanded to include a num-
ber of other biological parts which has already been characterized and available for synthetic biology
applications. For instance, DNA fragments encoding a subset of BioBrick standard biological parts
(http://partsregistry.org/) [15] could be converted into Entry clones by PCR amplification using the pre-
fix and suffix sequences that flank every BioBrick part, followed by Gateway BP recombination reactions.
Although the Entry clones presented here are for two-fragment recombinations, the Destination vectors
can be used for recombination reactions of three or more DNA fragments. This would be useful for the
assembly of a gene with a complex promoter.
In an effort to increase the flexibility of synthetic gene networks in yeast, we have also constructed two
new tunable transcriptional transactivators, AIDtTA and AIDrtTA. We showed that when O. sativa TIR1
gene is co-expressed, they were rapidly degraded in response to auxin. We also demonstrated that the
expression of the reporter gene by AIDtTA and AIDrtTA were controlled efficiently by NAA and/or DOX
added to the medium (Fig. 6-9). We constructed a destabilized version of Venus, yEVenus-Cln2PEST,
and used it to monitor the AIDtTA’s activity (Fig. 7). Because Venus has faster, improved maturation
properties of the chromophore [16], yEVenus-Cln2PEST may be better-suited than the original version,
GFP-Cln2PEST [10], as a reporter of the dynamics of synthetic gene networks. A unique advantage of
AIDtTA or AIDrtTA may be that the ’memory’ of gene activation can be erased rapidly by an auxin-
regulated protein degradation. The rapid degradation of these transactivators are however dependent
on the fine balance of their expression level and that of Tir1 protein: when AIDrtTA was expressed by
the strong TEF promoter, its degradation was retarded (Fig. 5D). The AID system therefore requires
fine-tuning of the expression level of its components to achieve the desired functionality. For example,
the expression level of OsTIR1 in yeast may be increased by adopting a codon-optimized version of the
ORF [17], thereby improving the efficiency of the degradation of AID-tagged target proteins.
An additional control may also be integrated into synthetic networks using these engineered transac-
tivators by making the TIR1 gene expression inducible. AIDtTA and AIDrtTA should also be functional
in other eukaryotic systems in principle, as AID system and the tetracycline-regulated transactivators
were demonstrated to work in higher eukaryotic cells [8, 9]. Because of the dominance of the auxin-
induced degradation over the doxycycline-regulated gene induction, AIDtTA and AIDrtTA may function
as Boolean logic devices in response to doxycycline and auxin, corresponding to NOR and N-IMPLY gate,
respectively. Recent work has also exploited post-transcriptional negative regulations to perform logic
operations NOT, AND, NAND and N-IMPLY, using RNA binding proteins that inhibit the translation
of transcripts harboring specific RNA motifs [18]. AIDtTA and AIDrtTA may be combined together with
other biological logic operation devices in eukaryotes [18–21].
The budding yeast Saccharomyces cerevisiae is an attractive system for synthetic biology because of
its vast resources and tools for biotechnology applications. Moreover, S. cerevisiae has been exploited as
a platform for synthesizing a complete genome [22, 23] and chromosome arms [24]. These studies have
presented a prospect of engineering a large-scale artificial gene network in yeast. Although the number
of biological parts customized for yeast synthetic biology is still limited, it is rapidly growing in recent
6years [25–27]. The multisite Gateway recombination method for assembling artificial genes may be a
useful addition to the toolbox for synthetic biology in yeast and also a valid approach in other organisms.
Materials and Methods
Yeast manipulations, strains and media
Genetic manipulations and transformations of yeast cells were performed as described [28]. After trans-
formation, cells were plated on synthetic complete medium (SC) lacking appropriate amino acids [28].
Transformed cells with plasmids were cultured in the selective media until the culture reaches early to
mid-log phase of growth (OD600 = 0.1 ∼ 1.0) for experiments. The yeast strains used in this study are
FY1679 (MATa/α GAL2/GAL2 HIS3/his3∆200 LEU2/leu2∆1 TRP1/trp1∆63 ura3−52/ura3−52;
EUROSCARF Acc. No. 10000D), YS114 (MATα GAL2 his3∆200 trp1∆63 ura3 − 52 :: ADH1 −
OsTIR1−9Myc, URA3; this study), MM017 (MATa his3∆1 leu2∆0 trp1∆63 ura3∆0 met15 :: TEF −
AIDrtTA; this study), YS008 (MATα his3∆1 leu2∆0 trp1∆63 ura3∆0 met15 :: ADH1 − OsTIR1 −
9Myc; this study), YS017 (MATa his3∆1 leu2∆0 trp1∆63 ura3∆0 lys2 :: TetO7 − CY C1TATA −
yEV enus − Cln2PEST − NLS; this study), YS081 (MATα his3∆1 leu2∆0 trp1∆63 ura3∆0; this
study), JW003 (MATa/α his3∆1/his3∆1 leu2∆0/leu2∆0 trp1∆63/trp1∆63 ura3∆0/ura3∆0 met15 ::
ADH1−OsTIR1−9Myc/MET15 LY S2/lys2 :: TetO7−CY C1TATA−yEV enus−Cln2PEST−NLS;
this study) and YS129 (MATa his3∆1 leu2∆0 trp1∆63 ura3∆0; this study), which are all congenic with
S288C. To integrate the Oryza sativa TIR1 gene, pNHK53 (an integration vector of ADH1-OsTIR1-
9Myc) [8] was linearized by StuI and transformed into FY1679. To derive YS114, the diploid strain
with an integrated pNHK53 was sporulated. Sporulations were performed as follows: Freshly streaked
cells on YPD plate were patch-streaked on GNA (5% glucose, 3% Difco nutrient broth (BD Bioscience;
cat. no. 234000), 1% yeast extract, 2% bacto-agar) and incubated overnight at 30◦C. The cells on
GNA were patch-streaked again on GNA and incubated overnight at 30◦C. A small quantity of cells
(equivalent to a medium-sized colony on a plate) was then suspended in 2.5ml of sporulation medium
(1% pottasium acetate, 0.5% zinc acetate) and incubated at 25◦C with vigorous shaking for up to a
week. The genetic selection of YS008, YS017 and MM017 strains were performed according to Sadowski
et al. [7], which describes the detailed methods of gene integration and disintegration. To create MM017,
pMM6 (Table 3) was linearized with MluNI (an isoschizomer of MscI) and transformed into YS129 for
integration. To derive YS008, pCM33 (integration vector of ADH1-OsTIR1-9Myc; see below for its
construction) was linearized by MluNI and transformed into YS129 for integration. To make YS017,
pCM36 (TetO7-CYC1TATA-yEVenus-Cln2PEST-NLS ; see below for its construction) was linearized by
NruI and transformed into YS081 strain. JW003 strain was made by mating YS008 and YS017. JW003
transformed with the plasmid pDHM19 (ADH1-AIDtTA) was used for the experiment shown in Fig. 7.
To test the regulation of AIDtTA and AIDrtTA by doxycycline and auxin (Fig. 5 to 9), YS114,
MM017 and YS129 strains were transformed with pCG103 (TetO7-CYC1TATA-yEVenus-Cln2PEST-
NLS ), pCG87 (TetO7-CYC1TATA-mCherry-NLS ), pCG84 (ADH1-tTA), pDHM19 (ADH1-AIDtTA),
pCG85 (ADH1-rtTA), pDHM20 (ADH1-AIDrtTA), pCG113 (TEF-rtTA), and pCG107 (TEF-AIDrtTA)
as indicated in each figure. Doxycycline (DOX) was added to cell cultures at the final concentration of
5 µg/ml. For the induction of protein degradation using AID system, 1-Naphthaleneacetic acid (NAA;
pottasium salt, Sigma cat. no. N1145) was added to cell cultures to 0.5mM, except the experiment
shown in Fig. 7 in which 2mM was used. We observed little inhibition of cell growth up to 2mM of NAA.
Phosphate-citrate buffer (64.2mM Na2HPO4 and 17.9mM citric acid, pH6.0) was added to SC medium to
prevent the acidification of the culture [29] when using NAA. To induce CUP1 promoter, copper nitrate
(Cu(NO3)2, Sigma cat. no. 223395) was added to the medium to 0.25mM. DOX, NAA, or copper nitrate
were added to cell cultures at OD600 = 0.2.
7Molecular biology techniques
Standard molecular biology techniques were used for DNA manipulations. DNA fragments were puri-
fied using a PCR purification kit or gel purification kit (Qiagen). DNA ligation was performed using
a rapid DNA ligation kit (Roche Applied Science). For PCR reactions, Pfu polymerase (Promega) or
Velocity DNA polymerase (Bioline) were used. PCR primers used in this study are listed in Table 4.
Plasmid clones created with PCR reactions were verified by DNA sequencing. The Gateway recombina-
tion reactions were performed using Multisite Gateway Pro Kits (Life Technologies). The donor vectors
(pDONR221P1-P5r, pDONR221P5-P2; Life Technologies), and destination vectors were prepared using
ccdB Survival T1R Chemically Competent E. coli (Life Technologies).
Construction of Destination vectors. The destination vectors containing a yeast centromere were
built upon the pRS vector series (pRS413, pRS414, pRS415 and pRS416) [6]. A. gossypii TEF termi-
nator was amplified by PCR from pAG25 [30], using the standard T7 sequencing primer and TEFt-F
primer. The amplified DNA was cut with NotI and SacI and cloned into the pRS vectors to create
pRS413TEFt, pRS414TEFt, pRS415TEFt and pRS416TEFt. S. cerevisiae CYC1 terminator was am-
plified from pCM183 [31] by PCR with CYC1F and CYC1R primers, cut with NotI and SacI and cloned
into the pRS413 vector digested with the same enzymes to create pRS413CYC1T. A cassette contain-
ing two recombination sites, attR1 and attR2, flanking the ccdB and CmR (chloramphenicol resistance)
genes was amplified by PCR from pDEST17 (Invitrogen), using primers attR1-F and attR2-R. The PCR
product was digested by SpeI and AvrII and cloned into pRS413CYC1T to yield pDEST413CYC1T. The
attR1-attR2 cassette with the ccdB and CmR genes was cut out from pDEST413CYC1T by XhoI and
XbaI and cloned into pRS413TEFt, pRS415TEFt and pRS416TEFt, which yielded pDEST413TEFt,
pDEST415TEFt and pDEST416TEFt, respectively. To create pDEST414TEFt, 2kb DNA fragment
containing the cassette and the TEF terminator was cut out from pDEST413TEFt by XhoI and SacI
and ligated to pRS414 digested with the same enzymes. Similarly, the XhoI-SacI DNA fragment from
pDEST413CYC1T was cloned into pRS414 to make pDEST414CYC1t. Although these pDEST plasmids
were functional as destination vectors, T7 terminator downstream of ccdB gene was found to be required
for efficient selection of expression clones. Therefore, DNA fragments harbouring the T7 terminator were
cut out from pDEST17 and cloned into these vectors, to create pDEST413TEFt7, pDEST414TEFt7,
pDEST415TEFt7, pDEST416TEFt7, pDEST413CYC1t7 and pDEST414CYC1t7 (Fig.1). pDEST375
was made by isolating the KpnI/SacI DNA fragment containing the Gateway attR1-attR2 cassette from
pDEST416TEFt7 and cloning it into pIS375 [7] using the same restriction sites.
Construction of promoter Entry clones. S. cerevisiae CUP1 promoter was amplified by PCR
from pYM-N1 [11] using the oligonucleotide primers B2-CUP1-F and B5-CUP1-R. S. pombe ADH1 pro-
moter was amplified from pCM245 [32] using B2-ADH-F and B5-ADH-R primers. S. cerevisiae TEF pro-
moter was amplified from pYM-N18 [11] using the primers B2-TET-F and B5-TET-R. A DNA fragment
containing TetO2 operator with the TATA region of S. cerevisiae CYC1 gene (CYC1TATA) was ampli-
fied from pCM171 [31] using the primers B2TetO-1 and B5TetO-1. Likewise, TetO7 with CYC1TATA
was amplified from pCM159 [31] using the same pair of primers. These PCR products were purified and
subjected to BP recombination reaction with pDONR221P5-P2 in vitro to create the plasmids listed in
Table 1.
Construction of ORF Entry clones. yEGFP ORF was amplified from pYM25 [11] using the
primers B5r-yEGFP-F2 and B1-yEGFP-R2. yEGFP-Cln2PEST ORF was obtained by PCR from pSVA13
[10] using B5r-yEGFP-F2 and B1-Cln2PEST. yEVenus ORF was amplified by PCR from pKT90 [33] using
the primers B5r-yEGFP-F2 and B1-yVenus-R2. mCherry ORF were amplified from pCS-memb-mCherry
(mCherry fused to a myristoylation motif; a kind gift from J.C. Smith, originally constructed by S. Mega-
son and S. Fraser, Caltech), using B5r-mCherry-F1 and B1-mCherry-R1 primers. A glycine linker and a
SV40 nuclear localization signal (NLS; amino acid sequence PGGGGPKKKRKVD) was added to the C-
terminus of yEVenus ORF by PCR using the primers B5r-yEGFP-F2 and B1-yEGFPNLS-R and pKT90
as a template. Likewise, mCherry-NLS was constructed by PCR using the primer pair B5r-mCherry-F1
8and B1-mCherryNLS-R, and pCG40 as a template. The plasmid for yEVenus-Cln2PEST (pCG98) was
created by inserting a Cln2PEST XmaI fragment into pYS61. The Cln2PEST sequence was amplified
by PCR using primers XmaI-PESTF and XmaI-PESTR, and pSVA13 as a template. tTA and rtTA
ORFs were amplified from pCM171 [31] and pCM251 [32] respectively, using the primers B5r-tTA and
B1-tTA. To create pCG72, OsTIR1-9Myc was amplified by PCR using primers B5r-TIR1 and B1-TIR1,
and pNHK36 [8] as a template. The amplified ORFs were cloned into pDONR221P1-P5r by Gateway BP
reaction to create the Entry clones in Table 2. Auxin inducible degron (AID) was fused to tTA and rtTA
using a method that combines a Gateway BP reaction in vitro and a homologous recombination in vivo
in E. coli [13]. For this, two PCR reactions were performed. First, a DNA fragment encoding AID was
amplified from pNHK12 [8] using the oligonucleotides AIDtTA-R and B5r-AIDGFPNLS (PCR product
1). Second, tTA and rtTA ORF were amplified using the primers AIDtTA-F and B1-tTA (PCR product
2). PCR product 1 and 2 have an overlapping sequence that mediates a homologous recombination in
vivo. These PCR products together with pDONR221P1-P5r were subjected to a BP reaction, followed
by a transformation into E. coli (DH5α strain), to create pYS57 (Entry clone of AIDrtTA) and pYS58
(AIDtTA).
Other plasmids. The integration vector pCM33 was made as follows: pCG81 (Table 3) was di-
gested by SphI/BspQI and blunt-ended by T4 DNA polymerase (New England Biolabs). The fragment
containing ADH1-OsTIR1-9Myc was purified and ligated to pIS375 [7], which was linearized by BamHI
and blunt-ended by Klenow fragment (Promega). pCM36 was created by inserting PvuII fragment
of pCM20 (Table 3) into pIS385 [7], which was cut by BamHI and blunt-ended by Klenow fragment.
pNHK12, pNHK36 and pNHK53 were obtained from the National Bio-Resource Project (NBRP) of
MEXT, Japan. The following plasmids were obtained from EUROSCARF (EUROpean Saccharomyces
Cerevisiae ARchive for Functional Analysis): pAG25, pCM159, pCM171, pCM183, pCM245, pCM251,
pIS375, pKT90, pYM25, pYM-N1, pYM-N18.
Microscopy and flow cytometry
Yeast cells were cultured in liquid SC medium lacking appropriate amino acids and mounted on a glass
slide for fluorescence microscopy. Images were acquired using a Zeiss Axioplan2 microscope with an
oil-immersion objective lens (100x) equipped with a CCD camera (Hamamatsu ORCA-ER) and Openlab
software (Perkin Elmer). For flow cytometry, cells were harvested by centrifugation, or by vacuum
filtration on nitrocellulose membranes (1.2µm, Millipore, cat. no. RAWP02500), re-suspended in ice-
cold 1xPBS and sonicated briefly before subjected to the analysis using LSRFortessa (BD Biosciences).
Fluorescence of 50,000 cells for each sample were measured by flow cytometry. Based on the FFS/SSC
values, the data were gated to remove cell debris and aggregates. The raw data for the remaining
cells, between 86% and 98% of the original sample, were exported to MATLAB (MATLAB, Natick,
Massachusetts: The MathWorks Inc., 2012) and binned in log scale (0 to 105, 100 bins). The scale of
each bin was normalized by the sum of all cells in the respective sample and plotted (Fig. 8). No
smoothing has been applied.
Western blotting
Protein extraction from yeast cells was conducted as described [34]. Standard techniques were used for
electrophoresis (SDS-PAGE) and Western blotting. Western blotting was performed using Amersham
ECL Plus Western Blotting detection reagent (cat no. RPN2132). The primary antibodies used were
anti-myc monoclonal (1:1000, Millipore, 9E10, *2 in Fig. 5A) or rabbit polyclonal antibody (1:5000,
Abcam, cat no. ab9106, *4 in Fig. 5B-D) and TetR monoclonal antibody (1:1000, Clontech, cat no.
631108, *1 in Fig. 5A; 1:1000, MoBiTec, TET02, *3 in Fig. 5B-D); the secondary antibodies were
anti-mouse IgG HRP-linked antibody (1:1000, Cell Signaling #7076) and anti-rabbit IgG HRP-linked
9antibody (1:1000, DAKO, cat no. P0217). Equal loading of protein extracts in SDS-PAGE was verified
by Ponceau S staining of blotted membranes.
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Figures
Figure 1. Gateway Destination vectors constructed in this study. (A) Yeast centromere
Destination vectors. Each vector contains ARSH4, CEN6, and a marker gene for maintenance in yeast.
(B) Yeast integration Destination vector (pDEST375). All vectors have an origin of replication in E.coli
(ori), attR1 and attR2 recombination sequences for Gateway LR reaction, ampicillin resistance
(AmpR), chloramphenicol resistance (CmR) and ccdB selection marker genes for cloning. attR1 and
attR2 are flanked by TEF or CYC1 terminator (T) and T7 terminator (Tt7) sequences as indicated.
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Figure 2. Gene assembly by Gateway LR recombination reaction. Yeast expression vectors
can be created by one-step recombination reaction using a promoter entry clone, an ORF entry clone
and a Destination vector. In the LR reaction, CmR and ccdB selection marker genes flanked by attR1
and attR2 are replaced by the assembled gene (promoter-ORF).
Figure 3. Gateway vector pDEST375 for chromosomal integration. pDEST375 harbors YIp-In
and YIp-Out sequences derived from the flanking region of MET15 gene. An integration vector made
by an LR reaction is first linearized by MluNI (MscI), which is transformed into yeast cells. It produces
a single-copy integration of the gene of interest at the MET15 locus. At this stage, the genotype is
URA3+MET15+. The chromosomal MET15 gene and the flanking plasmid sequences including the
URA3 marker gene are removed by homologous recombination between the duplicated YIp-Out
sequences. After this recombination event in vivo, the desired genotype of the strain with the stable
integrated gene (promoter-ORF ) is ura3−met15−. The other possible genotype without the integrated
gene after the recombination is ura3−MET15+ (strains with this genotype will be discarded). It
enables a recycling of URA3 marker gene for subsequent gene integrations at other loci in the genome.
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Figure 4. Fluorescent protein gene induction by CUP1 and ADH1 promoter. (A) Yeast cells
(YS129 strain) transformed with pCM25 (CUP1 -yEVenus-Cln2PEST-NLS) were cultured in the
presence or absence of copper nitrate for 1 hr (middle panels) and 6 hrs (bottom panels). Cells with no
copper nitrate are also shown in the upper panel. (B) Yeast cells (YS129) with pDHM57
(ADH1 -yEVenus-Cln2PEST-NLS). (C) Yeast cells (YS129) with pRN1 (ADH1 -yEVenus-NLS). Note
that the fluorescence images in (B) and (C) were captured with the same exposure time. DIC:
differential interference contrast; YFP: YFP filter channel for the detection of Venus fluorescence.
Scale bar = 5 µm.
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Figure 5. Auxin-induced degradation of AIDtTA and AIDrtTA detected by Western
blotting. OsTIR1 is tagged with 9xMyc epitope. Cells were treated with NAA or left untreated for the
periods as indicated. (A) The yeast strain with an integrated copy of OsTIR1 gene (::ADH1-OsTIR1;
YS114 strain) and ADH1-AIDtTA plasmid. (B) Control strain YS129 with ADH1-AIDtTA, YS114 with
ADH1-tTA, and YS114 with ADH1-AIDtTA plasmid. (C) YS129 and YS114 with ADH1-AIDrtTA
plasmid. (D) YS129 with TEF-AIDrtTA, YS114 with TEF-rtTA and YS114 with TEF-AIDrtTA
plasmid. Cells were harvested and subjected to Western blotting using anti-TetR (α− TetR, for tTA,
AIDtTA, rtTA and AIDrtTA) and anti-Myc (α−Myc, for OsTIR1) antibodies. Note that different
primary antibodies were used in Fig. 5A (indicated by *1 and *2) and B-D (*3 and *4); see Materials
and Methods. Arrowheads indicate non-specific proteins recognized by the primary antibodies, which
act as loading controls.
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Figure 6. Fluorescent reporter protein expression induced by AIDtTA. YS129 strain was
transformed with the plasmid constructs indicated above each panel. The activity of tTA and AIDtTA
was detected by mCherry fluorescent reporter protein expression. (A) TetO7-mCherry-NLS (reporter
plasmid) only, without doxycycline (-DOX). (B) ADH1-tTA and TetO7-mCherry-NLS. (C)
ADH1-AIDtTA and TetO7-mCherry-NLS. Cells were observed 7 hrs after addition of DOX. DIC:
differential interference contrast; mCherry: mCherry fluorescence was detected using TRITC filter.
Scale bar = 5 µm.
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Figure 7. Suppression of AIDtTA activity by doxycycline and NAA. The yeast strain with an
integrated copy of ADH1-OsTIR1 and a reporter TetO7-yEVenusCln2PEST-NLS gene was transformed
with the plasmid harboring ADH1-AIDtTA. The fluorescent reporter protein expression was examined
in the presence or absence of DOX and NAA as indicated. (A) Schematic diagram of the gene network
of the strain. (B) Expression of yEVenusCln2PEST in the absence of DOX and NAA. (C) Expression of
yEVenusCln2PEST after treatment with DOX or NAA alone or both for 1, 2, 3 and 4 hours. DIC:
differential interference contrast; YFP: YFP filter channel. Scale bar = 5 µm.
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Figure 8. Gene expression control by AIDtTA and AIDrtTA: flow cytometry analysis.
(A-F) The yeast strains YS129 (-OsTIR1) and YS114 (+OsTIR1) were transformed with a reporter
plasmid construct (TetO7-mCherry-NLS) together with the plasmid harboring the gene as labeled on
each panels. These transformed yeast cells were treated with either doxycycline (+DOX; broken green
lines) or NAA alone (+NAA; cyan), or both (+DOX & NAA; orange) for 7 hours, or left untreated (no
inducers; broken magenta), and analyzed by flow cytometry. Fluorescence of 50,000 cells for each
sample were measured. The data were gated to remove those of cell debris and aggregates, binned in log
scale (0 to 105, 100 bins) and plotted. The plots are offset at fluorescence = 4 arbitrary units.
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Figure 9. Gene expression control by AIDrtTA. (A) Schematic representation of the
experimental system. AIDrtTA activity was detected by mCherry fluorescent reporter protein
expression. (B) Yeast strains as indicated were cultured in the presence of doxycycline (+DOX), auxin
(+NAA), both doxycycline and auxin (+DOX & NAA), or in the absence (no inducer). Cells were
observed 6 hrs after addition of the inducers. (C) Yeast strain with an integrated copy of TEF-AIDrtTA
(MM017) was cultured in the presence or absence of doxycycline for 5 hours. DIC: differential
interference contrast; mCherry: mCherry fluorescence detected with TRITC filter. Scale bar = 5 µm.
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Tables
Table 1. Destination vectors created in this study
Plasmid Marker GenBank Acc. No.
pDEST413TEFt7 HIS3 JX901379
pDEST414TEFt7 TRP1 JX901380
pDEST415TEFt7 LEU2 JX901381
pDEST416TEFt7 URA3 JX901382
pDEST413CYC1t7 HIS3 JX901383
pDEST414CYC1t7 TRP1 JX901384
pDEST375 URA3,MET15∗1 KC614689
*1 5’ and 3’ flanking sequences of MET15.
Table 2. Entry clones created in this study
Plasmid Promoter
pYS1 S. cerevisiae CUP1
pYS2 S. pombe ADH1
pYS3 S. cerevisiae TEF
pYS6 TetO7-CYC1TATA
pYS7 TetO2-CYC1TATA
Plasmid ORF
pCG32 yEGFP
pDHM7 yEGFP-Cln2PEST
pCG55 yEVenus
pYS61 yEVenus-NLS∗1
pCG98 yEVenus-Cln2PEST-NLS
pCG40 mCherry
pYS60 mCherry-NLS
pYS19 tTA
pYS20 rtTA
pYS58 AIDtTA
pYS57 AIDrtTA
pCG72 OsTIR1-9Myc
Promoter Entry clones were created with pDONR221P5-P2 and ORF Entry clones with
pDONR221P1-P5r. ∗1 Significant cytoplasmic fluorescence was observed when overexpressed, for
example, by TEF promoter.
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Table 3. Expression plasmid vectors constructed by Gateway recombination method in
this study
Plasmid Promoter ORF Marker Destination vector
pCG52 S. cerevisiaeTEF mCherry LEU2 pDEST415TEFt7
pCG109 S. pombe ADH1 mCherry-NLS TRP1 pDEST414TEFt7
pCG57 S. cerevisiae TEF yEVenus LEU2 pDEST415TEFt7
pRN1 S. pombe ADH1 yEVenus-NLS LEU2 pDEST415TEFt7
pDHM57 S. pombe ADH1 yEVenus-Cln2PEST-NLS LEU2 pDEST415TEFt7
pCM25 S. cerevisiae CUP1 yEVenus-Cln2PEST-NLS LEU2 pDEST415TEFt7
pCG87 TetO7-CYC1TATA mCherry-NLS TRP1 pDEST414TEFt7
pCG103 TetO7-CYC1TATA yEVenus-Cln2PEST-NLS TRP1 pDEST414TEFt7
pCM20 TetO7-CYC1TATA yEVenus-Cln2PEST-NLS TRP1 pDEST415TEFt7
pCG84 S. pombe ADH1 tTA HIS3 pDEST413TEFt7
pCG85 S. pombe ADH1 rtTA HIS3 pDEST413TEFt7
pDHM19 S. pombe ADH1 AIDtTA HIS3 pDEST413TEFt7
pDHM20 S. pombe ADH1 AIDrtTA HIS3 pDEST413TEFt7
pCG112 ∗1 S. cerevisiae TEF tTA HIS3 pDEST413TEFt7
pCG113 S. cerevisiae TEF rtTA HIS3 pDEST413TEFt7
pCG106 ∗1 S. cerevisiae TEF AIDtTA HIS3 pDEST413TEFt7
pCG107 S. cerevisiae TEF AIDrtTA HIS3 pDEST413TEFt7
pMM6 ∗2 S. cerevisiaeTEF AIDrtTA URA3, MET15 pDEST375
pCG81 S. pombe ADH1 OsTIR1-9Myc URA3 pDEST416TEFt7
∗1 Yeast cells with these expression vectors showed poor growth with an unknown reason.
∗2 Integration vector.
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Table 4. PCR primers
Primer Sequence
T7 TAATACGACTCACTATAGGG
TEFt-F TTGCGGCCGCTCAGTACTGACAATAAAA
CYC1F AAGCGGCCGCATCATGTAATTAGT
CYC1R TTGAGCTCAAATTAAAGCCTTCGAGCGT
attR1-F ACCACTAGTACAAGTTTGTACAAAAAAGC
attR2-R GTTCCTAGGACCACTTTGTACAAGAA
B2-CUP1-F GGGGACCACTTTGTACAAGAAAGCTGGGTATAGTAAGCCGATCCCATTAC
B5-CUP1-R GGGGACAACTTTGTATACAAAAGTTGCTCTGTCGTCCGGATTTATGTGATG
B2-ADH-F GGGGACCACTTTGTACAAGAAAGCTGGGTAGCATGCCCTACAACAACTAA
B5-ADH-R GGGGACAACTTTGTATACAAAAGTTGGCAATTCTCTTGCTTAAAGAAAAGC
B2-TET-F GGGGACCACTTTGTACAAGAAAGCTGGGTAGAGCTCATAGCTTCAAAATG
B5-TET-R GGGGACAACTTTGTATACAAAAGTTGAAAACTTAGATTAGATTGCTATGCT
B2TetO-1 GGGGACCACTTTGTACAAGAAAGCTGGGTAGGCAGATCAATTCCTCGATC
B5TetO-1 GGGGACAACTTTGTATACAAAAGTTGTAATTTAGTGTGTGTATTTG
B5r-tTA GGGGACAACTTTTGTATACAAAGTTGTACAACATGTCTAGATTAGATAAAAG
B1-tTA GGGGACAAGTTTGTACAAAAAAGCAGGCTCTACCCACCGTACTCGTCA
AIDtTA-F GGTGCAGGCGCTGGAGCGGGTGCCATGTCTAGATTAGATAAAAGTAAA
AIDtTA-R TTTACTTTTATCTAATCTAGACATGGCACCCGCTCCAGCGCCTGCACC
B5r-AIDGFPNLS GGGGACAACTTTTGTATACAAAGTTGTACAAAATGATGGGCAGTGTCGAG
B5r-yEGFP-F2 GGGGACAACTTTTGTATACAAAGTTGTACAAAATGTCTAAAGGTGAAGAATTATTC
B1-yEGFP-R2 GGGGACAAGTTTGTACAAAAAAGCAGGCTTTATTTGTACAATTCATCCATACC
B1-yVenus-R2 GGGGACAAGTTTGTACAAAAAAGCAGGCTTTATTTGTACAATTCATCAATACC
B1-Cln2PEST GGGGACAAGTTTGTACAAAAAAGCAGGCTCTAGCTATATTACTTGGGTATTGC
B1-yEGFPNLS-R GGGGACAAGTTTGTACAAAAAAGCAGGCTGGTACCTCAGTCGACTTTTCTCTTTTT-
CTTTGGACCACCACCCCCGGGTTTGTACAATTCATCCATACC
B5r-mCherry-F1 GGGGACAACTTTTGTATACAAAGTTGTACAAAATGGTGAGCAAGGGCGAGGA
B1-mCherry-R1 GGGGACAAGTTTGTACAAAAAAGCAGGCTTTACTTGTACAGCTCGTCCA
B1-mCherryNLS-R GGGGACAAGTTTGTACAAAAAAGCAGGCTGGTACCTCAGTCGACTTTTCTCTTTTT-
CTTTGGACCACCACCCCCGGGCTTGTACAGCTCGTCCATGCC
XmaI-PESTF ATACCCCGGGTCTGGTGGTACCGCATCCAACTTGAACATTTC
XmaI-PESTR TCAACCCGGGACCACCTATTACTTGGGTATTGCCCATACC
B5r-TIR1 GGGGACAACTTTTGTATACAAAGTTGTACAAAATGACGTACTTCCCGGAG
B1-TIR1 GGGGACAAGTTTGTACAAAAAAGCAGGCTTTAGCTAGTGGATCCGTT
PCR primers used in this study. Sequences are in 5′ to 3′ direction.
